Diagnostic tests for urinary tract infections and antimicrobial resistance—a reality check between diagnostic innovation and implementation: a critical narrative review
Frontiers in Cellular and Infection Microbiology · 2026
DOI: 10.3389/fcimb.2026.1784139 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Vathsala Mohan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Commonwealth Scientific and Industrial Research Organisation (CSIRO), Health and Biosecurity, Westmead, NSW, Australia. Hauptthemen laut MEDLINE: Urinary Tract Infections, Drug Resistance, Bacterial, Diagnostic Tests, Routine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 178 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Urinary tract infections (UTIs) are a significant health concern worldwide, leading to substantial health and economic burden and contributing to the rise of antimicrobial resistance (AMR). Although there has been significant advancement in diagnostic technologies starting from conventional dipstick urinalysis to molecular assays and artificial intelligence (AI)-supported platforms, their clinical utility and impact still remain unclear. This is fundamentally due to the systemic barriers that hinder the implementation including cost, policy, and limitations to integrate into frontline healthcare and adoption by insurance agencies. This review focuses on critically reviewing UTI epidemiology, current and emerging diagnostics, and their significance in antimicrobial stewardship. We emphasise that bridging the gap between diagnostic innovation and clinical practice is essential to achieving meaningful milestones in AMR reduction. We are primarily arguing that addressing the policy inertia to diagnostic deployment with stewardship strategies is a crucial step for improving patient healthcare outcomes and preserving antimicrobial efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Commonwealth Scientific and Industrial Research Organisation (CSIRO), Health and Biosecurity, Westmead, NSW, Australia.
- Hahn-Schickard, Freiburg, Germany.
- Laboratory for MEMS Applications, IMTEK-Department of Microsystems Engineering, University of Freiburg, Freiburg, Germany.
Zitieren
APA
Mohan, V., & Mitsakakis, K. (2026). Diagnostic tests for urinary tract infections and antimicrobial resistance—a reality check between diagnostic innovation and implementation: a critical narrative review. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2026.1784139
Vancouver
Mohan V, Mitsakakis K. Diagnostic tests for urinary tract infections and antimicrobial resistance—a reality check between diagnostic innovation and implementation: a critical narrative review. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2026.1784139
BibTeX
@article{Mohan2026,
author = {Mohan, Vathsala and Mitsakakis, Konstantinos},
title = {Diagnostic tests for urinary tract infections and antimicrobial resistance—a reality check between diagnostic innovation and implementation: a critical narrative review},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
doi = {10.3389/fcimb.2026.1784139}
}
EUVIMED